Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole Oral Solution for Aspergilloma
NCT00005668Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary aspergilloma comparing Itraconazole with Placebo (2 arms). Status: completed.
02
Drugs
itraconazole
03
Conditions
pulmonary aspergilloma
Beyond the preview
Go deeper on NCT00005668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005668.